Diagnostic and predictive abilities of myokines in patients with heart failure
Advances in Protein Chemistry and Structural Biology · 2024
DOI: 10.1016/bs.apcsb.2023.12.021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Protein Chemistry and Structural Biology, 2024. Verfasst von Oleksandr O Berezin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Luzerner Psychiatrie AG, Department of Senior Psychiatrie, St. Urban, Switzerland. Hauptthemen laut MEDLINE: Heart Failure. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 302 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Myokines are defined as a heterogenic group of numerous cytokines, peptides and metabolic derivates, which are expressed, synthesized, produced, and released by skeletal myocytes and myocardial cells and exert either auto- and paracrine, or endocrine effects. Previous studies revealed that myokines play a pivotal role in mutual communications between skeletal muscles, myocardium and remote organs, such as brain, vasculature, bone, liver, pancreas, white adipose tissue, gut, and skin. Despite several myokines exert complete divorced biological effects mainly in regulation of skeletal muscle hypertrophy, residential cells differentiation, neovascularization/angiogenesis, vascular integrity, endothelial function, inflammation and apoptosis/necrosis, attenuating ischemia/hypoxia and tissue protection, tumor growth and malignance, for other occasions, their predominant effects affect energy homeostasis, glucose and lipid metabolism, adiposity, muscle training adaptation and food behavior. Last decade had been identified 250 more myokines, which have been investigating for many years further as either biomarkers or targets for heart failure management. However, only few myokines have been allocated to a promising tool for monitoring adverse cardiac remodeling, ischemia/hypoxia-related target-organ dysfunction, microvascular inflammation, sarcopenia/myopathy and prediction for poor clinical outcomes among patients with HF. This we concentrate on some most plausible myokines, such as myostatin, myonectin, brain-derived neurotrophic factor, muslin, fibroblast growth factor 21, irisin, leukemia inhibitory factor, developmental endothelial locus-1, interleukin-6, nerve growth factor and insulin-like growth factor-1, which are suggested to be useful biomarkers for HF development and progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Luzerner Psychiatrie AG, Department of Senior Psychiatrie, St. Urban, Switzerland.
- Department of Internal Medicine and Nephrology, VitaCenter, Zaporozhye, Ukraine.
- Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University, Salzburg, Austria.
- Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University, Salzburg, Austria. Electronic address: aeberezin@gmail.com.
Zitieren
APA
Berezin, O. O., Berezina, T. A., Hoppe, U. C., Lichtenauer, M., & Berezin, A. E. (2024). Diagnostic and predictive abilities of myokines in patients with heart failure. Advances in Protein Chemistry and Structural Biology. https://doi.org/10.1016/bs.apcsb.2023.12.021
Vancouver
Berezin OO, Berezina TA, Hoppe UC, Lichtenauer M, Berezin AE. Diagnostic and predictive abilities of myokines in patients with heart failure. Advances in Protein Chemistry and Structural Biology. 2024. doi:10.1016/bs.apcsb.2023.12.021
BibTeX
@article{Berezin2024,
author = {Berezin, Oleksandr O and Berezina, Tetiana A and Hoppe, Uta C and Lichtenauer, Michael and Berezin, Alexander E},
title = {Diagnostic and predictive abilities of myokines in patients with heart failure},
journal = {Advances in Protein Chemistry and Structural Biology},
year = {2024},
doi = {10.1016/bs.apcsb.2023.12.021}
}
EUVIMED